Buckley Capital’s Views on Liquidia Corp. (LQDA)
From Yahoo Finance: 2025-05-08 11:06:00
Buckley Capital Advisors released its Q1 2025 investor letter, reporting a -0.5% return for the quarter. Donald Trump’s tariff plans caused economic uncertainty, impacting the firm’s portfolio. Liquidia Corporation (NASDAQ:LQDA) saw a 25.46% one-month return and closed at $15.53 per share on May 7, 2025, with a market capitalization of $1.326 billion.
Liquidia Corporation (NASDAQ:LQDA) focuses on developing products for pulmonary arterial hypertension, a serious lung disease affecting half a million individuals globally. Despite its potential, the stock is not among the 30 most popular stocks among hedge funds, with 36 portfolios holding it at the end of Q4 2024. The firm sees greater promise in AI stocks for higher returns.
In another article, Liquidia Corporation (NASDAQ:LQDA) was covered with Jim Cramer’s hidden gems and undervalued stocks highlighted. For more hedge fund investor letters from Q1 2025, visit the website. Check out articles on Michael Burry selling stocks in 2024 and a new dawn coming to US stocks. No disclosures mentioned.
Read more at Yahoo Finance: Buckley Capital’s Views on Liquidia Corp. (LQDA)